Cosmos-Hub

CosmosID is a microbiome science and sequencing brand known for combining next-generation sequencing services with specialized bioinformatics to help researchers identify and characterize microorganisms. The company has supported clients in industry, academia, and clinical research, with experience across more than 20 sample types and customers in over 25 countries. CosmosID’s offerings include amplicon sequencing, shallow and deep shotgun metagenomic sequencing, metatranscriptomics, bacterial isolate sequencing, metabolomics, and genomic reporting. Its analysis services cover microbiome profiling, functional metagenomics, bacterial isolate characterization, and custom bioinformatics.

The CosmosID platform is designed to analyze microbial communities at species, subspecies, and strain level, including bacteria, viruses, phages, fungi, and protists, as well as antimicrobial resistance and virulence genes. Users can explore results through interactive visualizations and comparative analysis tools. The company also provides sample collection and logistics, project guidance, educational resources, and software access. CosmosID reports more than 12 years of experience and a record of award-winning bioinformatics. CosmosID, DNASense, and MS-Omics have merged to form Cmbio, which directs visitors to cmbio.io.